CHMP recommends approval of Cabazitaxel Accord for metastatic prostate cancer.- Accord Healthcare
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Cabazitaxel Accord (cabazitaxel), from… read more.